28
03/23
NEWS
In 2022 Chiesi Group has been confirmed as the 1st Italian...
Once again, Chiesi Group has been confirmed as the 1st Italian pharmaceutical company and the 3rd among the...
  • PRESS RELEASE
    Chiesi Group and Affibody collaborate to develop and...
    Chiesi Group and Affibody will collaborate closely to develop novel Affibody® molecules as innovative treatments for...